Stem cell technology in breast cancer: current status and potential applications

Rena Chiotaki, Hara Polioudaki, Panayiotis A Theodoropoulos Department of Biochemistry, School of Medicine, University of Crete, Heraklion, Greece Abstract: Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chiotaki R, Polioudaki H, Theodoropoulos PA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/3c5800a4b3ad4ccb810a8a42323ca84c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3c5800a4b3ad4ccb810a8a42323ca84c
record_format dspace
spelling oai:doaj.org-article:3c5800a4b3ad4ccb810a8a42323ca84c2021-12-02T00:13:22ZStem cell technology in breast cancer: current status and potential applications1178-6957https://doaj.org/article/3c5800a4b3ad4ccb810a8a42323ca84c2016-04-01T00:00:00Zhttps://www.dovepress.com/stem-cell-technology-in-breast-cancer-current-status-and-potential-app-peer-reviewed-article-SCCAAhttps://doaj.org/toc/1178-6957Rena Chiotaki, Hara Polioudaki, Panayiotis A Theodoropoulos Department of Biochemistry, School of Medicine, University of Crete, Heraklion, Greece Abstract: Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the tumor, identified as breast cancer stem cells (BCSCs). BCSCs underlie the mechanisms of tumor initiation and sustenance and are implicated in the dissemination of the primary tumor to metastatic sites, as they have been found circulating in the blood of breast cancer patients. The discovery of BCSCs has generated a great amount of interest among the scientific community toward their isolation, molecular characterization, and therapeutic targeting. In this review, after summarizing the literature on molecular characterization of BCSCs and methodologies used for their isolation, we will focus on recent data supporting their molecular and functional heterogeneity. Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings challenging their safety. Keywords: breast cancer stem cells, cancer stem cell heterogeneity, targeting cancer stem cells, circulating tumor cells, stem cell technologyChiotaki RPolioudaki HTheodoropoulos PADove Medical PressarticleBreast cancer stem cellscancer stem cell heterogeneitytargeting cancer stem cellscirculating tumor cellsstem cell technologyCytologyQH573-671ENStem Cells and Cloning: Advances and Applications, Vol 2016, Iss Issue 1, Pp 17-29 (2016)
institution DOAJ
collection DOAJ
language EN
topic Breast cancer stem cells
cancer stem cell heterogeneity
targeting cancer stem cells
circulating tumor cells
stem cell technology
Cytology
QH573-671
spellingShingle Breast cancer stem cells
cancer stem cell heterogeneity
targeting cancer stem cells
circulating tumor cells
stem cell technology
Cytology
QH573-671
Chiotaki R
Polioudaki H
Theodoropoulos PA
Stem cell technology in breast cancer: current status and potential applications
description Rena Chiotaki, Hara Polioudaki, Panayiotis A Theodoropoulos Department of Biochemistry, School of Medicine, University of Crete, Heraklion, Greece Abstract: Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the tumor, identified as breast cancer stem cells (BCSCs). BCSCs underlie the mechanisms of tumor initiation and sustenance and are implicated in the dissemination of the primary tumor to metastatic sites, as they have been found circulating in the blood of breast cancer patients. The discovery of BCSCs has generated a great amount of interest among the scientific community toward their isolation, molecular characterization, and therapeutic targeting. In this review, after summarizing the literature on molecular characterization of BCSCs and methodologies used for their isolation, we will focus on recent data supporting their molecular and functional heterogeneity. Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings challenging their safety. Keywords: breast cancer stem cells, cancer stem cell heterogeneity, targeting cancer stem cells, circulating tumor cells, stem cell technology
format article
author Chiotaki R
Polioudaki H
Theodoropoulos PA
author_facet Chiotaki R
Polioudaki H
Theodoropoulos PA
author_sort Chiotaki R
title Stem cell technology in breast cancer: current status and potential applications
title_short Stem cell technology in breast cancer: current status and potential applications
title_full Stem cell technology in breast cancer: current status and potential applications
title_fullStr Stem cell technology in breast cancer: current status and potential applications
title_full_unstemmed Stem cell technology in breast cancer: current status and potential applications
title_sort stem cell technology in breast cancer: current status and potential applications
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/3c5800a4b3ad4ccb810a8a42323ca84c
work_keys_str_mv AT chiotakir stemcelltechnologyinbreastcancercurrentstatusandpotentialapplications
AT polioudakih stemcelltechnologyinbreastcancercurrentstatusandpotentialapplications
AT theodoropoulospa stemcelltechnologyinbreastcancercurrentstatusandpotentialapplications
_version_ 1718403857407541248